Mendelian randomization study showed no causality between metformin use and lung cancer risk

Int J Epidemiol. 2020 Aug 1;49(4):1406-1407. doi: 10.1093/ije/dyz218.

Authors

Huaqiang Zhou^{1

2

3}, Jiayi Shen⁴, Wenfeng Fang^{1

2

3}, Jiaqing Liu⁴, Yaxiong Zhang^{1

2

3}, Yan Huang^{1

2

3}, Li Zhang^{1

2

3}

Affiliations

¹ Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
² State Key Laboratory of Oncology in South China, Guangzhou, China.
³ Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
⁴ Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

PMID: 31628798
DOI: 10.1093/ije/dyz218

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Causality
Humans
Lung Neoplasms* / epidemiology
Lung Neoplasms* / genetics
Mendelian Randomization Analysis
Metformin* / adverse effects

Substances

Metformin